Friday, October 14, 2022 12:15:41 PM
My understanding is this. And I have been wrong before. Basically, they start a new company, with a new management team. Their sole focus is Tollovir/vid. Todos will sell some of their 52% to investors. Give away some to new management team. And retain an unknown amount. If I had to guess I would say 25%. When (if) Tollovid/vir takes off. The hope is they will get bought out for a hundred million. Making it a great investment if it happens quickly. A decent investment if it takes awhile. And a crappy investment/bad decision if it goes under. Someone will then buy the IP for pennies on the dollar. But if it goes under. There probably wasn’t much there anyway. Unless it is miss managed. Which is a real possibility. I vote do it. Things are moving too slowly. Go big or go under.
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM